Abstract Body

Since the advent of HAART and PrEP, STI rates have increased in high risk men. However, it has not been clear if these increases were due to increased routine screening of HIV+ and PrEP patients, or due to increasing STI prevalence, or both.

Participants (Pts) were born male and were seen for ≥ 1 medical visit at a Boston health center specializing in HIV care between 2005 and 2015. Pts contributed person-time to any year in which a medical visit occurred. Gonorrhea (GC) or Chlamydia (CT) tests in different sites on the same day were considered 1 test in calculating the screening (S) and diagnoses (D) rates. We calculated the test-positivity rate (D/S; # positive tests / # tests), S rate (tests / 1,000 person-years) and diagnosis rate (positive tests / 1,000 person-years) adjusted for race, insurance status, sexual orientation, age, and year.

Between 2005 and 2015, 19,232 men had at least 1 clinic visit. Most (72.4%) were white; 6.0% were black, and 6.1% were Latino. Almost half self-reported as gay (42.6%) or bisexual (3.2%). Most had private health insurance (61.7%); 5.4% had Medicare, 4.6% had Medicaid, and 8.4% reported no insurance. Between 2005 and 2015, the overall STI diagnosis rate increased more than 7-fold for GC and 4-fold for CT (see Figure). In 2005, there were 10 GC and 25 CT diagnoses per 1,000 person-years, compared to 73 and 106 in 2015, respectively. Among HIV- men, the GC diagnosis rate was 8 per 1,000 person-years in 2005, 14 in 2010, and 69 in 2015, and 19, 27, and 95 for HIV+ men during the same time, with comparable increases for CT. The adjusted GC screening rate per 1,000 person years went from 386 in 2005 to 702 in 2010 to 1244 in 2015 for HIV- pts, and from 646 to 861 to 1231 for HIV+ pts in the same years. CT screening also increased. GC test positivity rate increased significantly between 2005 and 2015, but the CT test positivity rate only increased between 2010 and 2015. In 2015, the GC D/S was 4.8% for HIV- pts who were not using PrEP, 6.8% for PrEP users, and 7.7% for HIV+ pts; the CT D/S was 7.3%, 10.8%, and 10.4% for the respective groups.

Over the decade since 2005, both GC screening rates and test positivity increased significantly in at risk Boston men with similar trends in CT since 2010, suggesting increasing community disease burden. Test positivity rates were highest among HIV+ and PrEP patients, underscoring the need for routine bacterial STI screening for at risk men .